Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators.

Area of Science:

• Cardiology
• Electrophysiology
• Genetics

Background:

• Arrhythmic right ventricular cardiomyopathy (ARVC) poses a significant risk of sudden cardiac death.
• Current risk stratification methods for ARVC patients require refinement to identify individuals necessitating intervention.
• Automatic implantable defibrillators (ICDs) are crucial for preventing sudden death in high-risk patients.

Purpose of the Study:

• To establish risk stratification criteria for patients diagnosed with arrhythmic right ventricular cardiomyopathy (ARVC).
• To identify predictors of arrhythmic events and sudden cardiac death in ARVC.
• To inform guidelines for the implantation of automatic implantable defibrillators (ICDs) in ARVC management.

Main Methods:

• Retrospective analysis of 88 patients diagnosed with ARVC across three medical centers.
• Inclusion criteria focused on patients not currently treated with an automatic implantable defibrillator (ICD).
• Evaluation of clinical data to identify risk factors associated with subsequent arrhythmic deaths.

Main Results:

• Pre-enrollment sustained or nonsustained ventricular tachycardia (VT) emerged as a significant predictor of arrhythmic death.
• Decreased left ventricular function was identified as another critical risk factor for adverse arrhythmic events.
• These findings highlight specific clinical indicators for risk assessment in ARVC.

Conclusions:

• Sustained/nonsustained VT and impaired left ventricular function are proposed as key indicators for ICD implantation in ARVC patients.
• Implementing these risk factors into clinical guidelines can aid in preventing sudden cardiac death.
• This study provides a foundation for improved management strategies in ARVC.